Abingdon Health PLC

ABDX

Company Profile

  • Business description

    Abingdon Health PLC develops, manufactures, and distributes diagnostic devices and provides regulatory consultancy to diagnostics businesses. It offers integrated lateral flow CRO/CDMO services covering feasibility, manufacturing, packaging, kitting, documentation, and commercial support. Segments include Contract Development (milestone-based third-party work, revenue over time by completion), Contract Manufacturing (development/manufacturing via daily consultancy, revenue at customer control point), Product Sales (AbC-19TM, Pocket Diagnostic, PCRD tests, research antibodies, carriage; point in time), and Regulatory Services (IVD/medical device compliance, revenue over time), with key revenue from Regulatory Services. It operates in the UK, USA/Canada, Europe, and rest of world.

  • Contact

    York Biotech Campus
    Sand Hutton
    YorkYO41 1LZ
    GBR

    T: +44 1904406050

    E: [email protected]

    https://www.abingdonhealth.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Diagnostics & Research

    Fiscal Year End

    30 June 2026

    Employees

    129

Stocks News & Analysis

stocks

Older cohorts the budget losers, not necessarily the ASX listed insurers

Proposed legislation removes health insurance rebates.
stocks

Turnaround progressing for ASX share

Margins have rebased by shares are undervalued.
stocks

Investors overlooking ASX share’s potential

International expansion is a distraction from valuable local business.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,735.4083.10-0.94%
CAC 407,987.490.000.00%
DAX 4024,307.92357.351.49%
Dow JONES (US)49,686.12159.950.32%
FTSE 10010,323.75128.381.26%
HKSE25,675.18287.55-1.11%
NASDAQ26,090.73134.41-0.51%
Nikkei 22560,815.95593.34-0.97%
NZX 50 Index12,762.92202.09-1.56%
S&P 5007,403.055.45-0.07%
S&P/ASX 2008,505.3072.60-0.85%
SSE Composite Index4,131.533.86-0.09%

Market Movers